← Leaderboards
Glenn Short III
Atai Therapeutics, Inc.
$2,923,842
Attributed
$2,923,842
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$2,923,842 · 1
By mechanism
UG3$2,923,842 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Addiction”
- Taleen Hanania · Psychogenics, Inc.$21,254,211
- Jennifer McCormack · The Emmes Company, Llc$15,840,866
- Christina Mayer · Advanced Bioscience Laboratories, Inc.$9,340,093
- George Gaitanaris · Omeros Corporation$6,689,019
- Andrew Gardiner · Libero Pharma Limited$6,351,015
- Charles Daniel Meyers · Tempero Bio, Inc.$5,310,920
Research focus
AddictionAdherenceAffectAgonistAnalytical MethodArtificial IntelligenceAttenuatedBackBehavioral PharmacologyBiological AvailabilityBrainCandidate SelectionCardiacCardiovascular SystemCare CostsChemistryClinicClinical ResearchClinical TrialsClinical Trials DesignCommercializationComputer AssistedConditioned Place PreferenceAbstinence